Imaging Biomarkers

11-Nov-2010 - Large pharma has been seeking new biomarkers for years – all part of their drug discovery process, but often only as an afterthought in the development process. That’s changed over recent years, but by-and-large the bulk of biomarker work remains in the hands of small -to -medium-sized companies ...

A Change of Culture for Healthcare

29-Oct-2010 - Today the management of culture within healthcare is becoming more and more important. It is now viewed as a necessary part of the health system reform. In the United Kingdom, the National Health Service (NHS) reforms are based on the premise that any major cultural transformation of an ...

Manufacturing Safety Raises Concern

20-Oct-2010 - Last week Pharmaceutical heads met as a result of a drugs recall after a pill mix up of breast cancer pills. The drug, Fresenius Kabi’s Anastrozole, was made by the German company’s subsidiary in India. The ingredient mix up led to the voluntary recall of 7,192 bottles, each containing 30 ...

Pharmaceutical Question Time

08-Oct-2010 - With access, cost and quality concerns plaguing pharmaceutical delivery systems both in the US as well as globally, the Next Generation Pharmaceutical Drug Discovery committee has been formed to confront, assess and deliver new strategies to secure the future of the industry. Meeting in Miami, ...

Pharma to Make the Private Public

09-Sep-2010 - Last week, leaders from companies like AstraZeneca, GlaxoSmithKline, Pfizer and Roche met in Vienna in a closed meeting to discuss the future of the pharma industry. Fears of layoffs at pharmaceutical companies are once again dominating the news, but could there be a less painful way to save ...

Pharma ‘HTS’ the Mark with Screening

22-Jul-2010 - Back in May, it was announced that new stem cell research would reduce the need for animal testing. Now, we are really beginning to see the benefits of groundbreaking science that is not reliant on out dated methods of testing. The proposal was that by reprogramming powerful stem cells from ...

From Regional to Global: How Pfizer reworked the pharmaceutical business model

22-Mar-2010 - Jorge Puente, Regional President of WW Pfizer gave an inside look into how Pfizer became global. He explained to Adam Burns, Editor in Chief of meettheboss.tv, that the fact he did not know there was a Pfizer international office until they invited him to do a lecture, really became a telltale ...

M&A - The trials and tribulations

Former Schering & Plough CEO speaks out about the pharmaceutical Industry. Where they went wrong and the solutions, which lead to the successful sale

16-Feb-2010 - With the recent announcement of the Merck & Co acquisition of Schering & Plough, Fred Hassan the former Chief Executive Officer has been speaking to Meettheboss.TV on the future of the pharmaceutical Industry, mergers, acquisitions and the resistance felt? Last year Fred over saw the $41.1 ...

Pharmaceutical executives spend an extra 9 hours a month learning (and teaching) online

17-Jun-2009 - A study run by online business networking service MeettheBoss shows that pharmaceutical executives are spending an extra 9 hours a month online sharing their professional experiences and learning from their peers. MeettheBoss surveyed 15,000 of its 200,000 executive members to understand more ...

MeettheBoss for the pharmaceutical industry

21,000 Pharmaceutical executives opt for business over social

22-May-2009 - There has been no shortage of conversation lately about current problems facing the pharmaceutical industry. Communication is vital to work through the current economic crisis. Time management is a constant battle for executives who are now turning to online networking sites to liaise effectively ...